White House to announce new drug pricing deals with biotech companiesThe Trump administration plans to announce a new round of drug-pricing agreements with several midsized biotech companies on Monday, according to people familiar with the matter.Aug 26, 2026·2 sourcesHealthcare PolicyTrump administrationUS health policy & drug pricingPharmaceutical Industry00